Whalegun
Home

Alnylam Pharmaceuticals ALNY spent $390K on lobbying in Q2 2025 · Medicare, Trade

Trade details

Type
Lobbying report
Amount
$390,000
Quarter
Q2 2025
Stock
Alnylam Pharmaceuticals ALNY
Client
Alnylam Pharmaceuticals
Reported
25/07/20

Down 11.4% from last quarter

What else happened in Alnylam Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/05/31~25/07/30

Alnylam Pharmaceuticals's other lobbying reports